Aquatic Capital Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-1,600
Closed -$23K – 1539
2023
Q2
$23K Sell
1,600
-2,100
-57% -$29.9K ﹤0.01% 1109
2023
Q1
$54K Sell
3,700
-5,800
-61% -$97K ﹤0.01% 878
2022
Q4
$160K Buy
+9,500
New +$164K 0.01% 780

Other funds holding OPRX

Aquatic Capital Management's OPRX Position: Q3 2023 in Review

Aquatic Capital Management sold out of OptimizeRx (OPRX) in Q3 2023, closing a stake of 1,600 shares — an estimated $23K sold.

Aquatic Capital Management first reported a position in OPRX in Q4 2022 and held it in 3 quarters. The position peaked at $160K in Q4 2022. 94 funds tracked by Wall St. Rank hold OPRX as of Q3 2023.

  • Aquatic Capital Management reported no remaining OptimizeRx position as of Q3 2023 after selling out during the quarter.
  • Aquatic Capital Management sold 1,600 OptimizeRx shares in Q3 2023, an estimated $23K.
  • Aquatic Capital Management first reported a position in OptimizeRx in Q4 2022 and held it in 3 quarters.
  • Aquatic Capital Management's OptimizeRx position peaked at $160K in Q4 2022.
  • 94 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2023.

Based on Aquatic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.